CareDx CDNA Product revenue — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CareDx in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about CareDx's product revenue — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CareDx's product revenue — total revenue?
- CareDx (CDNA) reported product revenue — total revenue of $10.35M in Q1 2026.
- How has CareDx's product revenue — total revenue changed year-over-year?
- CareDx's product revenue — total revenue decreased by 4.3% year-over-year, from $10.81M to $10.35M.
- What is the long-term trend for CareDx's product revenue — total revenue?
- Over 4 years (2021 to 2025), CareDx's product revenue — total revenue has grown at a 15.9% compound annual growth rate (CAGR), from $26.83M to $48.38M.
- What does product revenue — total revenue mean?
- This metric represents the total gross revenue generated from the sale of specialized testing services, diagnostic products, and digital solutions tailored for transplant patients and clinical caregivers. It serves as a primary indicator of market adoption and commercial scale for the company's precision medicine portfolio. Tracking this revenue stream helps investors evaluate the company's ability to monetize its genomics-based information offerings within the transplant healthcare ecosystem.